Expression and Cellular Localization of Messenger RNA for Plasminogen Activator Inhibitor Type 1 in Human Astrocytomas in Vivo

Cancer Research

Volumn 54, Issue 13, 1994, Pages 3329-3332

  Nicolson, Garth L ^a   Tomonaga, Masamichi ^d   Mohanam, Saqjeeva ^a   Rao, Jasti S ^a  

^a Department of Neurosurgery ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; ASTROCYTOMA; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; RNA ANALYSIS;

ASTROCYTOMA; BASE SEQUENCE; BLOTTING, NORTHERN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0028360524     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Danø K., Andreasen, P.A., Grndahl-Hansen, J., Kxistensen, P., Nielsen, L.S., and Skriver, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44: 139-266, 1985.
2. Liotta, L.A., Steeg, P.S., and Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
3. Vassalli, J.D., Sappino, A.P., and Belin, D. The plasminogen activator/plasmin system. J. Clin. Invest., 88: 1067-1072, 1991.
4. Cubellis, M.V., Andreasen, P., Ragno, P., Mayer, M., Dane, IC, and Blasi, F. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA, 86: 4828-4832, 1989.
5. Kundsen, B.S., Harpel, P.C., and Nachman, R.L. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J. Clin. Invest., 80: 1082-1089, 1987.
6. Erickson, L.A., Hekman, C.M., and Loskutoff, D.J. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc. Natl. Acad. Sci. USA, 82: 8710-8714, 1985.
7. Schleef, R.R., Higgins, D.L., Pillemer, E., and Levitt, L.J. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J. Clin. Invest., 83: 1747-1752, 1989.
8. Páramo, J.A., Alfaro, M.J., and Rocha, E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor-relationship to deep vein thrombosis and influence of prophylaxis. Thromb. Haemostasis, 54: 713-716, 1985.
9. Keeton, M., Eguchi, Y., Sawdey, M., Ahn, C., and Loskutoff, D.J. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am. J. Pathol., 142: 59-70, 1993.
10. Russel, D.S., and Rubinstein, L.J. Pathology of tumors of the nervous system, Ed. 5. Baltimore: Williams and Wilkins, 1989.
11. Pöllänen, J., Saksela, O., Salonen, E.M., Andreasen, P., Nielsen, L., Danø, K., and Vaheri, A. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol., 104: 1085-10%, 1987.
12. Sitrin, R.G., Gyetko, M.R., Kole, K.L., McKeever, P., and Varani, J. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines. Cancer Res., 50: 4957-4961, 1990.
13. Kono, S., Rao, J.S., Bruner, J.M., and Sawaya, R. Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors. J. Neuropathol. Exp. Neurol., 53: 256-262, 1994.
14. Rao, J.S., Ray ford, A., Morantz, R.A., Festoff, B.W., and Sawaya, R. Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors. J. Neuro-Oncol., 17: 215-221, 1993.
15. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156159, 1987.
16. Ginsburg, D., Zeheb, R., Yang, A.Y., Rafferty, U.M., Andreasen, P.A., Nielsen, L., Dano, K., Lebo, R.V., and Gelehrter, T.D. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J. Clin. Invest., 78: 1673-1680, 1986.
17. Laiho, M., and Keski-Oja, J. Growth factors in the regulation of pericelluar proteolysis: a review. Cancer Res., 49: 2533-2553, 1989.
18. Sawaya, R., and Highsmith, R. Plasminogen activator activity and molecular weight patterns in human brain tumors. J. Neurosurg., 68: 73-79, 1988.
19. Owensby, D.A., Morton, P.A., Wun, T.C., and Schwartz, A.L. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin. J. Biol. Chem., 266: 4334-4340, 1991.
20. Shirasuna, K., Saka, M., Hayashido, Y., Yoshioka, H., Sugiura, T., and Matsuya, T. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation. Cancer Res., 53: 147-152, 1993.
21. Blasi, F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays, 15: 105-111, 1993.
22. Olson, D., Pöllänen, J., Hoyer-Hansen, G., Renne, E., Sakaguchi, K., Wun, T.C., Appella, E., Danø K., and Blasi, F. Internalization of the urokinase plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J. Biol. Chem., 267: 9129-9133, 1992.
23. Sprengers, E.D., and Kluft, C. Plasminogen activator inhibitors. Blood, 69: 381-387, 1987.
24. Folkmam, J., and Klagsbrun, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
25. Sawdey, M., Podor, T.J., and Loskutoff, D.J. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-α. J. Biol. Chem., 264: 10396-10401, 1989.
26. Schleef, R.R., Bevilacqua, M.P., Sawdey, M., Gimbrone, M.A., Jr., and Loskutoff, D.J. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem., 263: 5797-5803, 1988.